Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-21 Purchase | 2026-04-23 6:50 pm | Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner | 2,815,315 | $4.44 | $12,499,999 | 1,652,426 (Indirect) | View |
| 2026-04-21 Purchase | 2026-04-23 6:48 pm | Prelude Therapeutics Inc | PRLD | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,815,315 | $4.44 | $12,499,999 | 1,652,426 (Indirect) | View |
| 2025-03-25 Purchase | 2025-03-27 4:40 pm | Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer | 100,000 | $0.6925 | $69,250 | 480,123 (Direct) | View |
| 2025-03-25 Purchase | 2025-03-27 4:37 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 675,000 | $0.6925 | $467,438 | 3,669,054 (Indirect Direct) | View |
| 2025-03-20 Purchase | 2025-03-24 5:03 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 20,416 | $0.73028 | $14,909 | 2,994,054 (Indirect Direct) | View |
| 2025-03-14 Purchase | 2025-03-18 4:27 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 39,105 | $0.75335 | $29,460 | 2,973,638 (Indirect Direct) | View |
| 2025-03-12 Purchase | 2025-03-14 08:02 am | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 97,500 | $0.71348 | $69,564 | 2,934,533 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-09 Option Award | 2026-06-10 4:44 pm | N/A 2036-06-08 | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 76,000 | $0 | 76,000 (Indirect) | View |
| 2026-06-09 Option Award | 2026-06-10 4:15 pm | N/A 2036-06-08 | Prelude Therapeutics Inc | PRLD | Dorton Katina Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:15 pm | N/A 2036-06-08 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:13 pm | N/A 2036-06-08 | Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner | 38,000 | $0 | 38,000 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:13 pm | N/A 2036-06-08 | Prelude Therapeutics Inc | PRLD | Sandor Victor Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2026-06-09 Option Award | 2026-06-10 4:12 pm | N/A 2036-06-08 | Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2026-05-01 Option Award | 2026-05-04 4:10 pm | N/A 2036-04-30 | Prelude Therapeutics Inc | PRLD | Morris Charles Q Chief Medical Officer | 450,000 | $4.7 | 450,000 (Direct) | View |
| 2026-04-27 Other | 2026-04-28 5:14 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 1,407,000 | $0 | 9,289,882 (Indirect) | View |
Ownership | 2026-04-28 5:13 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 7,882,882 (Indirect) | View |
Ownership | 2026-03-19 7:39 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Brusky Sean P. Chief Business Officer | 0 | $0 | 850,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-05 4:14 pm | N/A 2036-02-03 | Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-05 4:12 pm | N/A 2036-02-03 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-05 4:11 pm | N/A 2036-02-03 | Prelude Therapeutics Inc | PRLD | Lim Bryant David CLO, CFO, Corp Sec. | 275,000 | $0 | 275,000 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-05 4:10 pm | N/A 2036-02-03 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 837,000 | $0 | 837,000 (Direct) | View |
| 2025-11-05 Option Award | 2025-11-07 4:28 pm | N/A 2035-11-04 | Prelude Therapeutics Inc | PRLD | Sandor Victor Director | 121,285 | $0 | 121,285 (Direct) | View |
| 2025-10-17 Option Award | 2025-10-20 4:16 pm | N/A 2035-10-16 | Prelude Therapeutics Inc | PRLD | Dorton Katina Director | 76,000 | $0 | 76,000 (Direct) | View |
| 2025-10-04 Tax Withholding | 2025-10-07 07:05 am | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 3,355 | $1.47 | 105,667 (Direct) | View |
| 2025-10-04 Exercise | 2025-10-07 07:05 am | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 9,375 | $0 | 105,667 (Direct) | View |
| 2025-07-04 Tax Withholding | 2025-07-08 4:06 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 3,355 | $0.7939 | 109,022 (Direct) | View |
| 2025-07-04 Exercise | 2025-07-08 4:06 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 9,375 | $0 | 109,022 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-13 4:45 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 152,000 | $0 | 152,000 (Indirect) | View |
| 2025-06-12 Option Award | 2025-06-13 4:15 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | Sandor Victor Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-13 4:15 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | Dier Mardi Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-13 4:14 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | FRIEDMAN PAUL A Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-13 4:13 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | Bonita David P Director 10% Owner | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-13 4:13 pm | N/A 2035-06-11 | Prelude Therapeutics Inc | PRLD | Babler Martin Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-04-04 Tax Withholding | 2025-04-07 4:11 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 3,355 | $0.675 | 112,377 (Direct) | View |
| 2025-04-04 Exercise | 2025-04-07 4:11 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 9,375 | $0 | 112,377 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-05 4:34 pm | N/A 2035-02-04 | Prelude Therapeutics Inc | PRLD | Lim Bryant David CLO, CFO, Corp Sec. | 200,000 | $0 | 200,000 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-05 4:32 pm | N/A 2035-02-04 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-05 4:32 pm | N/A 2035-02-04 | Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-05 4:31 pm | N/A 2035-02-04 | Prelude Therapeutics Inc | PRLD | Huang Jane President, CMO | 200,000 | $0 | 200,000 (Direct) | View |